MeiraGTx Holdings Free Cash Flow Over Time
| MGTX Stock | USD 5.92 0.10 1.72% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out MeiraGTx Holdings Performance and MeiraGTx Holdings Correlation. MeiraGTx |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MeiraGTx Holdings. If investors know MeiraGTx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MeiraGTx Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.20) | Revenue Per Share 0.13 | Quarterly Revenue Growth (0.92) | Return On Assets (0.37) | Return On Equity (0.92) |
The market value of MeiraGTx Holdings PLC is measured differently than its book value, which is the value of MeiraGTx that is recorded on the company's balance sheet. Investors also form their own opinion of MeiraGTx Holdings' value that differs from its market value or its book value, called intrinsic value, which is MeiraGTx Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MeiraGTx Holdings' market value can be influenced by many factors that don't directly affect MeiraGTx Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MeiraGTx Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if MeiraGTx Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MeiraGTx Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Free Cash Flow Analysis
Compare MeiraGTx Holdings PLC and related stocks such as Ideaya Biosciences, AnaptysBio, and Keros Therapeutics Free Cash Flow Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDYA | (14 M) | (14 M) | (14 M) | (14 M) | (14 M) | (14 M) | (14 M) | (14 M) | (29.3 M) | (40.7 M) | 55 M | (58.4 M) | (90.6 M) | (117.6 M) | (111.7 M) |
| ANAB | (5.8 M) | (5.8 M) | (5.8 M) | (5.8 M) | 14.5 M | (9.9 M) | (9.1 M) | (19.7 M) | (49.6 M) | (70.3 M) | (14.7 M) | (47.3 M) | (74 M) | (121.6 M) | (115.5 M) |
| KROS | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | (16.3 M) | (37.2 M) | (63.2 M) | (71.3 M) | (127 M) | (120.6 M) |
| QURE | (22.1 M) | (22.1 M) | (16.2 M) | (14 M) | (54.2 M) | 9.4 M | (89.4 M) | (69.9 M) | (80.3 M) | (105.3 M) | (144.3 M) | 270.5 M | (162.7 M) | (153.1 M) | (145.4 M) |
| RCKT | (6.9 M) | (6.9 M) | (6.9 M) | (6.5 M) | (9.7 M) | (17.8 M) | (37.8 M) | (26.2 M) | (55.2 M) | (87.9 M) | (103.7 M) | (128.9 M) | (186.8 M) | (211.4 M) | (200.8 M) |
| RYTM | (17.8 M) | (17.8 M) | (17.8 M) | (19.2 M) | (7 M) | (7 M) | (24.3 M) | (29.6 M) | (62.8 M) | (126.1 M) | (122.2 M) | (151.4 M) | (177.7 M) | (136.2 M) | (129.4 M) |
| SLDB | (4.2 M) | (4.2 M) | (4.2 M) | (4.2 M) | (4.2 M) | (4.2 M) | (20.5 M) | (45.5 M) | (78 M) | (97.1 M) | (57.5 M) | (79 M) | (101 M) | (95.7 M) | (100.5 M) |
| CNTB | (91.3 M) | (91.3 M) | (91.3 M) | (91.3 M) | (91.3 M) | (91.3 M) | (91.3 M) | (91.3 M) | (91.3 M) | (91.3 M) | (28 M) | (592.5 M) | (103.6 M) | (48.2 M) | (50.6 M) |
| ABOS | (6.8 M) | (6.8 M) | (6.8 M) | (6.8 M) | (6.8 M) | (6.8 M) | (6.8 M) | (6.8 M) | (6.8 M) | (6.8 M) | (7.5 M) | (18 M) | (35.3 M) | (43.1 M) | (40.9 M) |
| ETON | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (19.9 M) | (22.4 M) | (8 M) | 2 M | 6 M | 6.3 M |
| NUVB | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (36.7 M) | (68.5 M) | (96.5 M) | (68.1 M) | (71.5 M) |
| ELDN | (9.3 M) | (9.3 M) | (9.3 M) | (15.5 M) | (21.1 M) | (41.8 M) | (36.5 M) | (14.9 M) | (11.9 M) | (13.9 M) | (15.2 M) | (28.9 M) | (28.4 M) | (39.5 M) | (37.6 M) |
| GBIO | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (60.3 M) | (75.7 M) | (97.8 M) | (111.2 M) | (60.1 M) | (63.1 M) |
| KRON | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (18 M) | (47.5 M) | (122.2 M) | (91.5 M) | (79.3 M) | (83.2 M) |
| ERAS | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (71.4 M) | (98.5 M) | (119.8 M) | (103 M) | (108.1 M) |
| CCCC | (19.7 M) | (19.7 M) | (19.7 M) | (19.7 M) | (19.7 M) | (19.7 M) | (19.7 M) | (19.7 M) | (19.7 M) | 54.3 M | (67.9 M) | (88.2 M) | (111.4 M) | (108.5 M) | (103.1 M) |
| EWTX | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (14.8 M) | (34.2 M) | (58.2 M) | (97.7 M) | (92.8 M) |
MeiraGTx Holdings PLC and related stocks such as Ideaya Biosciences, AnaptysBio, and Keros Therapeutics Free Cash Flow description
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.My Equities
My Current Equities and Potential Positions
| MeiraGTx Holdings PLC | MGTX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
USD 5.92
Additional Tools for MeiraGTx Stock Analysis
When running MeiraGTx Holdings' price analysis, check to measure MeiraGTx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MeiraGTx Holdings is operating at the current time. Most of MeiraGTx Holdings' value examination focuses on studying past and present price action to predict the probability of MeiraGTx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MeiraGTx Holdings' price. Additionally, you may evaluate how the addition of MeiraGTx Holdings to your portfolios can decrease your overall portfolio volatility.